Updating the DrugPatentWatch Biologics Module
DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence - Ein Podcast von DrugPatentWatch
Kategorien:
Before the passage of the Biologic Patent Transparency Act DrugPatentWatch’s biologic patent data was cited as a reason why the law should not be passed. Thankfully, the Act advanced, and additional clarity is now available for biologic patents, and so DrugPatentWatch has radically updated the biologics section to take advantage of newly-available datasets. The new […] Source
